| Composition: | Sitagliptin Phosphate Monohydrate 100mg + Dapagliflozin Propanediol Monohydrate 10mg |
| Packaging: | 10x10 |
✓ DAPAGLIFLOZIN A highly potent, reversible & selective sodium-glucose cotransporter-2 inhibitor indicated worldwide for the treatment of Type 2 diabetes Well tolerated ✓ SITAGLIPTIN An orally administered, potent & highly selective inhibitor of dipeptidyl peptidase-4 (DPP-4) and is the first agent of its class to be approved for use in the management of adults with Type 2 diabetes Well tolerated and led to clinically meaningful reductions in glycemic parameters, blood pressure, and body weight